Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew T Jackson

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Regulatory Toxicology and Pharmacology : RTP|April 25, 2015
Improving the power of long term rodent carcinogenicity bioassays by adjusting the experimental designMatthew T Jackson
Dalton Transactions (Cambridge, England : 2003)|July 13, 2019
A quantitative study of vapor diffusions for crystallizations: rates and solvent parameter changesMichael J Wen, Matthew T Jackson, Charles M Garner
Vascular Medicine (London, England)|April 25, 2022
Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PADShea E Hogan, Mark R Nehler, Sonia Anand, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
TMEM33 deletion potentiates anti-tumor CD8 <sup>+</sup> T cell immunityMatthew T Jackson, Tianming Zhao, Gusztav Milotay, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Regulatory Toxicology and Pharmacology : RTP|April 25, 2015
Improving the power of long term rodent carcinogenicity bioassays by adjusting the experimental designMatthew T Jackson
Dalton Transactions (Cambridge, England : 2003)|July 13, 2019
A quantitative study of vapor diffusions for crystallizations: rates and solvent parameter changesMichael J Wen, Matthew T Jackson, Charles M Garner
Vascular Medicine (London, England)|April 25, 2022
Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PADShea E Hogan, Mark R Nehler, Sonia Anand, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
TMEM33 deletion potentiates anti-tumor CD8 <sup>+</sup> T cell immunityMatthew T Jackson, Tianming Zhao, Gusztav Milotay, et al.
Pageof 1